| Swetha Priya Chaparala, MD | |
|
1270 Prince Ave Suite 201, Athens, GA 30606 | |
| (706) 475-7055 | |
| Not Available |
| Full Name | Swetha Priya Chaparala |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Location | 1270 Prince Ave Suite 201, Athens, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295398964 | NPI | - | NPPES |
| Entity Name | Piedmont Hospitalist Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548219660 PECOS PAC ID: 1951299163 Enrollment ID: O20040309000820 |
News Archive
While botulinum toxin is commonly known as a cosmetic treatment for facial lines and wrinkles, a growing body of evidence suggests that "Botox" can also be an effective treatment for certain sports injuries and chronic pain conditions, according to a review in the June issue of Current Sports Medicine Reports, official journal of the American College of Sports Medicine.
A group led by Starr Investment Holdings said Monday that it is buying MultiPlan Inc., which helps manage claims for large health insurers. The price was $4.4 billion, according to a person close to the deal, who spoke on condition of anonymity because the companies did not disclose terms (2/17).
On Oct. 11, 2011, the FDA approved a labeling supplement for EUFLEXXA (1% sodium hyaluronate) that provides 26-week efficacy data from the FLEXX trial, as well as, 52-week safety data to demonstrate the safety of repeated injection cycles.
More than 3000 adolescents die every day, totaling 1.2 million deaths a year, from largely preventable causes, according to a new report from the World Health Organization and partners.
› Verified 2 days ago
| Entity Name | Piedmont Athens Primary Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245746783 PECOS PAC ID: 0648520841 Enrollment ID: O20180910002202 |
News Archive
While botulinum toxin is commonly known as a cosmetic treatment for facial lines and wrinkles, a growing body of evidence suggests that "Botox" can also be an effective treatment for certain sports injuries and chronic pain conditions, according to a review in the June issue of Current Sports Medicine Reports, official journal of the American College of Sports Medicine.
A group led by Starr Investment Holdings said Monday that it is buying MultiPlan Inc., which helps manage claims for large health insurers. The price was $4.4 billion, according to a person close to the deal, who spoke on condition of anonymity because the companies did not disclose terms (2/17).
On Oct. 11, 2011, the FDA approved a labeling supplement for EUFLEXXA (1% sodium hyaluronate) that provides 26-week efficacy data from the FLEXX trial, as well as, 52-week safety data to demonstrate the safety of repeated injection cycles.
More than 3000 adolescents die every day, totaling 1.2 million deaths a year, from largely preventable causes, according to a new report from the World Health Organization and partners.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Swetha Priya Chaparala, MD 1199 Prince Ave #70, Athens, GA 30606 Ph: () - | Swetha Priya Chaparala, MD 1270 Prince Ave Suite 201, Athens, GA 30606 Ph: (706) 475-7055 |
News Archive
While botulinum toxin is commonly known as a cosmetic treatment for facial lines and wrinkles, a growing body of evidence suggests that "Botox" can also be an effective treatment for certain sports injuries and chronic pain conditions, according to a review in the June issue of Current Sports Medicine Reports, official journal of the American College of Sports Medicine.
A group led by Starr Investment Holdings said Monday that it is buying MultiPlan Inc., which helps manage claims for large health insurers. The price was $4.4 billion, according to a person close to the deal, who spoke on condition of anonymity because the companies did not disclose terms (2/17).
On Oct. 11, 2011, the FDA approved a labeling supplement for EUFLEXXA (1% sodium hyaluronate) that provides 26-week efficacy data from the FLEXX trial, as well as, 52-week safety data to demonstrate the safety of repeated injection cycles.
More than 3000 adolescents die every day, totaling 1.2 million deaths a year, from largely preventable causes, according to a new report from the World Health Organization and partners.
› Verified 2 days ago
Bannur Ramanna Nandeesh, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1199 Prince Ave, Athens, GA 30606 Phone: 706-475-5076 | |
Krupal Jay Hari, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 242 King Avenue, Suite 210, Athens, GA 30606 Phone: 706-475-1700 Fax: 706-475-1790 | |
Mr. Ashwin Thatti, Internal Medicine Medicare: Medicare Enrolled Practice Location: 1500 Oglethorpe Ave Ste 500c, Athens, GA 30606 Phone: 706-546-7484 | |
Dr. Stephen William Wilde, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 700 Sunset Dr, Suite 501, Athens, GA 30606 Phone: 706-208-0065 Fax: 706-459-8693 | |
Dr. James S Miller, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1199 Prince Ave, Athens, GA 30606 Phone: 706-475-1700 Fax: 706-546-1787 | |
Dr. Paul Peteet, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 55 Carlton St, Athens, GA 30602 Phone: 706-542-8621 Fax: 706-583-0217 | |
Diana T Blake, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2470 Daniells Bridge Rd Ste 231, Athens, GA 30606 Phone: 706-769-3362 Fax: 706-769-5675 |